CTAS Form 144 details $3.84 M proposed insider stock sale

Rhea-AI Filing Summary

Cintas Corp. (CTAS) Form 144 reveals a proposed insider sale of 17,301 common shares, about 0.004 % of the company’s 403.8 M shares outstanding. At the recent market price, the block is valued near $3.84 million. The shares were obtained the same day via a cash-settled stock-option exercise and will be sold through Fidelity Brokerage Services on or around 28 Jul 2025 on Nasdaq. No other insider sales during the past three months are reported, and the filer attests to possessing no undisclosed adverse information.

Positive

• Sale represents only 0.004 % of shares outstanding, suggesting minimal market impact and no dilution risk.

Negative

• Insider plans to liquidate $3.8 M in stock, which some investors may view as a modest confidence signal downgrade.

Insights

Corporate Governance Analyst

TL;DR (20 words): Insider plans to sell $3.8 M in CTAS stock; size is immaterial to float, so governance impact is neutral.

The filing signals routine liquidity by an insider following an option exercise. The block equals roughly 0.004 % of shares outstanding and poses no dilution risk. Rule 144 disclosure maintains transparency, and the attestation of no material non-public information reduces governance concerns. Overall, the sale is too small to alter ownership structure or signal deteriorating insider confidence.

Portfolio Manager

TL;DR (22 words): $3.8 M CTAS insider sale is modest; unlikely to move the stock but bears monitoring for additional selling patterns.

Relative to CTAS’s ~$60 B market cap, the proposed sale is negligible. Liquidity absorption should be seamless given CTAS’s average daily volume. However, persistent insider selling can erode sentiment, so investors may watch subsequent Forms 4 and 144 for trend confirmation. In isolation, today’s notice does not warrant portfolio action.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	17301	3843071.13	403786963	07/28/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/28/2025	Stock Option Exercise	Issuer			17301	07/28/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Cintas (CTAS) shares are being sold under this Form 144?

The filing covers 17,301 common shares.

What is the approximate dollar value of the proposed CTAS sale?

The aggregate market value is about $3.84 million.

What percentage of Cintas's outstanding shares does this sale represent?

Roughly 0.004 % of the 403.8 million shares outstanding.

When is the planned sale date for the CTAS shares?

The filer lists an approximate sale date of 28 July 2025.

Were any CTAS shares sold by this insider in the past three months?

The filing states "Nothing to Report" for prior 3-month sales.

How were the shares being sold originally acquired?

They were obtained via a cash-settled stock-option exercise on 28 July 2025.